Related Experiment Video
Updated: Jul 15, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Pseudocoarctation as cause of a refractory hypertension
Alessio Amico1, Jean Luc Michaud, Oliver Baron
1Service de Chirurgie Cardiaque, Centre Hospitalier Universitaire de Nantes, Nantes, France. alessioamico@tiscali.it
Pseudocoarctation of the aorta, a condition affecting the aortic arch, can cause severe hypertension. This case highlights a stenotic variant leading to difficult-to-treat high blood pressure.
Area of Science:
- Cardiovascular Medicine
- Medical Diagnostics
- Clinical Case Reports
Background:
- Pseudocoarctation of the aorta is a congenital anomaly characterized by a localized narrowing of the descending aorta at the aortic isthmus.
- Unlike true coarctation, pseudocoarctation typically does not involve a significant pressure gradient across the narrowed segment.
- It is often an incidental finding or associated with other cardiovascular abnormalities.
Observation:
- This report details a rare case of pseudocoarctation of the aorta presenting with severe, refractory hypertension.
- The patient exhibited symptoms indicative of significantly elevated blood pressure that did not respond to standard antihypertensive therapies.
- Diagnostic imaging confirmed the presence of a stenotic pseudocoarctation, implying a functional impact despite the absence of a typical pressure gradient.
Findings:
- A stenotic pseudocoarctation of the aorta was identified as the underlying cause of the patient's severe hypertension.
- The anatomical abnormality, despite not being a true coarctation, was functionally significant enough to induce a hypertensive state.
- This finding challenges the traditional understanding that pseudocoarctation is hemodynamically insignificant.
Implications:
- This case underscores the importance of considering pseudocoarctation of the aorta in the differential diagnosis of severe, unexplained hypertension, particularly in younger individuals.
- It suggests that even without a pressure gradient, stenotic pseudocoarctation can lead to significant clinical consequences requiring specific management strategies.
- Further research into the pathophysiology and long-term outcomes of functionally significant pseudocoarctation is warranted to optimize patient care.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Angina II: Classification
Measurement of Blood Pressure
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hypertension II: Pathophysiology
Hypertension I: Introduction